Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric ...

The higher dosage was shown to help the average patient lose 21% of their body weight ...

A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.

Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out.

GoodRx reports that the FDA has approved oral semaglutide (Wegovy) for weight loss, offering an alternative to injections with similar results.

There’s no denying the popularity of weight-loss drugs in the United States, with one in eight adults relying on GLP-1s to ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

The appetite for weight-loss drugs, known as glp-1 agonists, has been insatiable since they hit the market a decade ago. In 2024 global spending on them reached $54bn, a figure that is sure to rise in ...

This “reverse dieting” phase gives your body time to slowly adapt to each increase while still maintaining its new weight.

Intermittent fasting is unlikely to lead to greater weight loss for overweight or obese adults than traditional diets, or ...

Want to stay incredibly strong, lean, energized, healthy and happy into your 70s, 80s, 90s and beyond? Unbreakable author Vonda Wright, MD, is on a mission to help you (and all women!) do just that.